Delin Wang
- Urology top 5%
- Urinary Bladder and Prostate Research 4
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ 4
-
- Prostate Cancer Treatment and Research 8
- Prostate Cancer Diagnosis and Treatment 7
- Ferroptosis and cancer prognosis 5
- Renal cell carcinoma treatment 4
- Rheumatology top 10%
-
- Bladder and Urothelial Cancer Treatments 4
-
- Epigenetics and DNA Methylation 4
- Cited by
- UrologyCell BiologyCancer Research
- Journals
- Frontiers in Oncology (5 papers)PLoS ONE (4 papers)International Journal of Surgery (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Delin Wang
54 papers receiving 654 citations
Peers
Comparison fields: 5 of 110
- Urology 121
- Cell Biology 132
- Cancer Research 97
- Pulmonary and Respiratory Medicine 203
- Rheumatology 91
Countries citing papers authored by Delin Wang
This map shows the geographic impact of Delin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delin Wang more than expected).
Fields of papers citing papers by Delin Wang
This network shows the impact of papers produced by Delin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delin Wang. The network helps show where Delin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Delin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 16 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 19 | |
| 14 | 2020 | 8 | |
| 15 | 2019 | 7 | |
| 16 | 2015 | 10 | |
| 17 | 2012 | 5 | |
| 18 | 2010 | 14 | |
| 19 | 2009 | 73 | |
| 20 | On electronic commerce | 2008 | 13 |
About Delin Wang
Delin Wang is a scholar working on Pulmonary and Respiratory Medicine, Urology and Cancer Research, having authored 68 papers that have together received 666 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Ferroptosis and cancer prognosis (5 papers), Renal cell carcinoma treatment (4 papers), Urinary Bladder and Prostate Research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Epigenetics and DNA Methylation (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). The work is most often cited by research in Urology (121 citations), Cell Biology (132 citations) and Cancer Research (97 citations). Delin Wang has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Keong Tatt Foo, Wujiang Liu, He Jiang, Xia Sheng, Hong Gee Sim, Kok Bin Lim, Lui Shiong Lee, Wenbin Li, Linjian Jiang and Xiumin Zhao. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, International Journal of Surgery, Pesticide Biochemistry and Physiology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.